Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr₹1,091 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹419 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr
Mar2020₹1,091 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr
11.66
Mar2020 ₹1,091 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,649.4 Cr -1.9% -9.5% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.9%

-9.5%

15.6%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses